LION THERAPEUTICS Trademark

Trademark Overview

On Wednesday, December 7, 2022, a trademark application was filed for LION THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LION THERAPEUTICS trademark a serial number of 97707296. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Tuesday, October 8, 2024. This trademark is owned by SPEID & ASSOCIATES INC.. The LION THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development
lion therapeutics

General Information

Serial Number97707296
Word MarkLION THERAPEUTICS
Filing DateWednesday, December 7, 2022
Status653 - SUSPENSION LETTER - MAILED
Status DateTuesday, October 8, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 5, 2023
Primary Code042
First Use Anywhere DateFriday, March 18, 2022
First Use In Commerce DateFriday, March 18, 2022

Trademark Owner History

Party NameSPEID & ASSOCIATES INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
Addresssan diego, CA 92130

Trademark Events

Event DateEvent Description
Saturday, December 10, 2022NEW APPLICATION ENTERED
Thursday, January 5, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 12, 2023ASSIGNED TO EXAMINER
Tuesday, September 19, 2023NON-FINAL ACTION WRITTEN
Thursday, November 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 19, 2023NON-FINAL ACTION E-MAILED
Tuesday, September 19, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, November 16, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 27, 2023SUSPENSION LETTER WRITTEN
Wednesday, December 27, 2023LETTER OF SUSPENSION E-MAILED
Wednesday, December 27, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, March 20, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, August 27, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 27, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 8, 2024SUSPENSION LETTER WRITTEN
Tuesday, October 8, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 8, 2024LETTER OF SUSPENSION E-MAILED
Thursday, April 10, 2025SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, August 27, 2024ASSIGNED TO LIE

Related Keywords

therapeutics lion development research pharmaceutical